$RMTG Surges Forward with AI-Powered Regenerative Medicine Breakthrough

⚡ Regenerative Medical Technologies Group (OTCID: $RMTG) is on fire. Just days after launching the ISSCA Mobile App, the company unveiled ISSCA AI™ Clinical Intelligence Platform — a powerful new AI system designed to support physicians with data interpretation, workflow optimization, predictive modeling, and personalized care in regenerative and longevity medicine.
Built on a proven 30+ country physician network and millions of patient records, ISSCA AI™ creates a connected digital ecosystem that deepens engagement and opens scalable new revenue streams.

💵 Strong Q1 2026 Results:
\- Revenue +93% to $2.64M
\- Gross Profit +87%
\- Operating Income +70% to $230K
\- Training revenue +433% • Product sales +102%

🌐 With a global network, recurring Turnkey memberships, biologics supply, and now AI infrastructure, RMTG is perfectly positioned at the intersection of regenerative medicine and health technology.

CEO David Christensen: “ISSCA AI™ is a major step toward combining biological science with computational tools.”

📈 Momentum is building fast. $RMTG offers exciting growth potential in one of healthcare’s hottest sectors.

News & More:
finance.yahoo.com/quote/RMTG/

Website:
regenmedtechgroup.com/ir